Voiding Dysfunction

New Products: BPH surgical robot granted FDA de novo requestOther products highlighted in this round-up include a plate for studying infections caused by the long-term use of catheters and a new indication for sunitinib malate (SUTENT).
Study: Monopolar TURP utilization on the declineAlthough monopolar transurethral resection of the prostate remains the standard of care for bladder outlet obstruction secondary to BPH, its utilization has decreased in recent years, according to a recent study.
Combined imaging technique feasible in POP repairReconstruction of anterior compartment defects using magnetic resonance-visible vaginal mesh implants in combination with post-surgical three-dimensional imaging is feasible and yields reproducible results, researchers report.
Urethroplasty delay results in more complex repairDelay to urethroplasty for bulbar urethral strictures is associated with repetitive interventions, stricture lengthening, and more complex repairs that have a greater risk for failure, while scheduling-related delay to reconstruction exposes men to risk for stricture-related complications, according to separate studies presented at the AUA annual meeting in Boston.
Uro Pipeline: NDA submitted for non-metastatic castration-resistant PCa agentOther pipeline products discussed in this round-up include and advanced renal cell carcinoma agent, a bladder cancer detection agent, and a BPH treatment.
Sacral neuromodulation, botulinum show equal efficacyIn patients with refractory urgency urinary incontinence (UUI), sacral neuromodulation (InterStim) and onabotulinumtoxinA (Botox) produce similar reductions in mean daily UUI episodes, according to 24-month follow-up data on patients treated in a randomized trial.
SNS vs. botulinum: Caveats, considerations
IC/BPS: One-fourth of patients have Hunner lesionsAbout one-fourth of patients with interstitial cystitis/bladder pain syndrome have Hunner lesions in the bladder visible on cystoscopy.
Repeat hydrodistention found safe in treating ICRepeated hydrodistention as therapy for interstitial cystitis has a low complication rate and does not decrease bladder capacity over time.
UTI incidence high, urine culture-directed care underutilizedGreater use of culture-directed care represents an opportunity to improve management of women with uncomplicated UTIs, researchers say.